Browse > Article

Clinical Features and Incidence of Skin Cancer and Precancerous Lesions after Solid Organ Transplantation: A 22-year Single-center Experience in Korea  

Park, Chan Seong (Department of Dermatology, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Park, Ji-Hye (Department of Dermatology, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Lee, Jong Hee (Department of Dermatology, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Lee, Dong-Youn (Department of Dermatology, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Lee, Joo-Heung (Department of Dermatology, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Yang, Jun-Mo (Department of Dermatology, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Publication Information
Korean journal of dermatology / v.56, no.10, 2018 , pp. 603-608 More about this Journal
Abstract
Background: It is well known that skin cancer and precancerous disease develop more frequently in patients undergoing solid organ transplantation than normal populations in the normal population in Western countries. However, to date, the clinical and demographic features of skin cancer and precancerous disease after solid organ transplantation are not established in Asian countries. We evaluated the clinical and demographic features of primary skin cancer and precancerous lesions after solid organ transplantation and compared these with the trends observed in Western countries. Methods: We retrospectively reviewed the medical records of patients who underwent kidney, liver, heart, and lung transplantation between January 1995 and April 2017 and who developed skin cancer or precancerous lesions after transplantation. The various lesions observed were squamous and basal cell carcinoma, malignant melanoma, Kaposi sarcoma, Bowen's disease, and actinic keratosis. Results: We identified 4604 patients who received organ transplant. The mean age of patients was 44.8 years (male, 64.6%; female, 35.4%), and the sum of the person-year of observation time was 31,024 person-years. The incidence rate per 100,000 person-years was 29.01 for squamous cell carcinoma, 19.34 for basal cell carcinoma, 6.45 for malignant melanoma 3.22 for Kaposi sarcoma, and 74.17 for Bowen's disease and actinic keratosis. The incidence rate per 100,000 person-years was the highest in patients undergoing heart transplantation (610.50), followed by those who underwent kidney transplantation (136.54) and liver transplantation (90.15). Koreans showed lower incidence rates than those observed in Westerners. Conclusion: The incidence of primary skin cancer and precancerous lesions after solid organ transplantation in Koreans was lower than that in Westerners. Squamous cell carcinoma was the most common skin cancer in patients undergoing solid organ transplantation and the incidence rate of skin cancer and precancerous lesions was the highest in patients undergoing heart transplantation.
Keywords
Organ transplantation; Precancerous lesion; Skin cancer;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003;348:1681-1691   DOI
2 Berg D, Otley CC. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002;47:1-17; quiz 18-20   DOI
3 Ishikawa N, Tanabe K, Tokumoto T, Shimmura H, Yagisawa T, Goya N, et al. Clinical study of malignancies after renal transplantation and impact of routine screening for early detection: a single-center experience. Transplant Proc 2000;32:1907-1910   DOI
4 Thiagarajan CM, Divakar D, Thomas SJ. Malignancies in renal transplant recipients. Transplant Proc 1998;30:3154-3155   DOI
5 Park GH, Chang SE, Won CH, Lee MW, Choi JH, Moon KC, et al. Incidence of primary skin cancer after organ transplantation: an 18-year single-center experience in Korea. J Am Acad Dermatol 2014;70:465-472   DOI
6 Zhang J, Ma L, Xie Z, Guo Y, Sun W, Zhang L, et al. Epidemiology of post-transplant malignancy in Chinese renal transplant recipients: a single-center experience and literature review. Med Oncol 2014;31:32   DOI
7 Rizvi SMH, Aagnes B, Holdaas H, Gude E, Boberg KM, Bjortuft O, et al. Long-term change in the risk of skin cancer after organ transplantation: a population-based nationwide cohort study. JAMA Dermatol 2017;153:1270-1277   DOI
8 Garrett GL, Blanc PD, Boscardin J, Lloyd AA, Ahmed RL, Anthony T, et al. Incidence of and risk factors for skin cancer in organ transplant recipients in the United States. JAMA Dermatol 2017;153:296-303   DOI
9 Krynitz B, Edgren G, Lindelof B, Baecklund E, Brattstrom C, Wilczek H, et al. Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008--a Swedish population-based study. Int J Cancer 2013;132:1429-1438   DOI
10 Roche CD, Dobson JS, Williams SK, Quante M, Popoola J, Chow JW. Malignant and noninvasive skin tumours in renal transplant recipients. Dermatol Res Pract 2014;2014:409058
11 Hartevelt MM, Bavinck JN, Kootte AM, Vermeer BJ, Vandenbroucke JP. Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation 1990;49:506-509   DOI
12 Luppi M, Barozzi P, Torelli G. Skin cancers after organ transplantation. N Engl J Med 2003;349:612-614; author reply 612-614   DOI
13 Jensen P, Moller B, Hansen S. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 2000;42:307
14 Lindelof B, Sigurgeirsson B, Gabel H, Stern RS. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 2000;143:513-519
15 Pritchett EN, Doyle A, Shaver CM, Miller B, Abdelmalek M, Cusack CA, et al. Nonmelanoma skin cancer in nonwhite organ transplant recipients. JAMA Dermatol 2016;152:1348-1353   DOI
16 Lee JH, Kim YH, Han KD, Park YM, Lee JY, Park YG, et al. Incidence of actinic keratosis and risk of skin cancer in subjects with actinic keratosis: a population-based cohort study. Acta Derm Venereol 2018;98:382-383   DOI
17 Oh CM, Cho H, Won YJ, Kong HJ, Roh YH, Jeong KH, et al. Nationwide trends in the incidence of melanoma and non-melanoma skin cancers from 1999 to 2014 in South Korea. Cancer Res Treat 2017
18 Ong CS, Keogh AM, Kossard S, Macdonald PS, Spratt PM. Skin cancer in Australian heart transplant recipients. J Am Acad Dermatol 1999;40:27-34   DOI
19 Lampros TD, Cobanoglu A, Parker F, Ratkovec R, Norman DJ, Hershberger R. Squamous and basal cell carcinoma in heart transplant recipients. J Heart Lung Transplant 1998;17:586-591
20 Kwa RE, Campana K, Moy RL. Biology of cutaneous squamous cell carcinoma. J Am Acad Dermatol 1992;26:1-26   DOI
21 Bergfelt L, Emilson A, Lindberg M, Scheynius A. Quantitative and 3-dimensional analysis of Langerhans cells in basal cell carcinoma. A comparative study using light microscopy and confocal laser scanning microscopy. Br J Dermatol 1994;130:273-280   DOI
22 Kripke ML. Antigenicity of murine skin tumors induced by ultraviolet light. J Natl Cancer Inst 1974;53:1333-1336   DOI
23 Haeffner AC, Zepter K, Elmets CA, Wood GS. Analysis of tumor-infiltrating lymphocytes in cutaneous squamous cell carcinoma. Arch Dermatol 1997;133:585-590   DOI
24 Gatter KC, Morris HB, Roach B, Mortimer P, Fleming KA, Mason DY. Langerhans' cells and T cells in human skin tumours: an immunohistological study. Histopathology 1984;8:229-244   DOI
25 Fortina AB, Piaserico S, Caforio AL, Abeni D, Alaibac M, Angelini A, et al. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients. Arch Dermatol 2004;140:1079-1085
26 Ulrich C, Schmook T, Sachse MM, Sterry W, Stockfleth E. Comparative epidemiology and pathogenic factors for nonmelanoma skin cancer in organ transplant patients. Dermatol Surg 2004;30:622-627
27 Frezza EE, Fung JJ, van Thiel DH. Non-lymphoid cancer after liver transplantation. Hepatogastroenterology 1997;44:1172-1181
28 Ho WL, Murphy GM. Update on the pathogenesis of post-transplant skin cancer in renal transplant recipients. Br J Dermatol 2008;158:217-224
29 Magruder JT, Crawford TC, Grimm JC, Kim B, Shah AS, Bush EL, et al. Risk factors for de novo malignancy following lung transplantation. Am J Transplant 2017;17:227-238   DOI
30 Taylor RS, Griffiths CE, Brown MD, Swanson NA, Nickoloff BJ. Constitutive absence and interferon-gammainduced expression of adhesion molecules in basal cell carcinoma. J Am Acad Dermatol 1990;22:721-726   DOI